Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Change in Cash: 2009-2024

Historic Change in Cash for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $64.5 million.

  • Cross Country Healthcare's Change in Cash rose 42148.75% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.6 million, marking a year-over-year decrease of 5277.83%. This contributed to the annual value of $64.5 million for FY2024, which is 37842.11% up from last year.
  • According to the latest figures from FY2024, Cross Country Healthcare's Change in Cash is $64.5 million, which was up 37842.11% from $13.5 million recorded in FY2023.
  • In the past 5 years, Cross Country Healthcare's Change in Cash registered a high of $64.5 million during FY2024, and its lowest value of -$564000.0 during FY2021.
  • For the 5-year period, Cross Country Healthcare's Change in Cash averaged around $16.1 million, with its median value being $2.6 million (2022).
  • As far as peak fluctuations go, Cross Country Healthcare's Change in Cash tumbled by 19929.58% in 2021, and later skyrocketed by 55531.91% in 2022.
  • Annual analysis of 5 years shows Cross Country Healthcare's Change in Cash stood at $568000.0 in 2020, then plummeted by 199.3% to -$564000.0 in 2021, then soared by 555.32% to $2.6 million in 2022, then skyrocketed by 425.31% to $13.5 million in 2023, then soared by 378.42% to $64.5 million in 2024.
  • Its Change in Cash stands at $64.5 million for FY2024, versus $13.5 million for FY2023 and $2.6 million for FY2022.